Revium Rx (RVRC) Current Assets (2024 - 2025)

Revium Rx (RVRC) reported Current Assets of $3.1 million for Q4 2025, down 43.9% on a YoY basis from $5.5 million in Q4 2024, and down 43.9% sequentially from $5.5 million in Q4 2024.

Revium Rx (RVRC) Current Assets (2024 - 2025) Analysis & Trends

Revium Rx (RVRC) has 2 years of Current Assets data on file, last reported at $3.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 43.9% year-over-year to $3.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.1 million (down 43.9% YoY), and the FY2025 full-year result was $3.1 million, down 43.9% from the prior year.
  • Current Assets eased to $3.1 million in Q4 2025, from $5.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $5.5 million in Q4 2024 to a low of $3.1 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Veeva Systems 31.59 Bn 24.28 Bn 662.02 Mn 8.06 Bn
2 BrightSpring Health Services 14.75 Bn 13.85 Bn 482.22 Mn 2.69 Bn
3 Healthequity 8.24 Bn 7.98 Bn 256.31 Mn 466.53 Mn
4 10x Genomics 5.91 Bn 5.37 Bn 106.18 Mn 669.73 Mn
5 Hinge Health 5.90 Bn 5.58 Bn 154.23 Mn 540.05 Mn
6 MiniMed 4.50 Bn 4.21 Bn 480.00 Mn 1.35 Bn
7 Waystar Holding 4.43 Bn 4.36 Bn 216.84 Mn 386.61 Mn
8 Doximity 3.91 Bn 3.16 Bn 125.97 Mn 944.26 Mn
9 Privia Health 3.19 Bn 2.77 Bn - 966.02 Mn
10 Revium Rx 101.42 Mn 98.71 Mn - 3.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.10 Mn
Dec 31, 2024 5.52 Mn